• About
  • Services
  • Clients
  • Client Media
    • Client News
    • Client Videos
    • CEO Insights
    • PCG Podcasts
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 19 Feb

    Myomo® Signs Nationwide Payer Network Agreement with HOMELINK

    CAMBRIDGE, Mass., February 19, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with HOMELINK which will enable Myomo to process… Read More..

    Share this:
  • 18 Feb

    SNGX: KOL Interview with Dr. Brian Poligone, an Investigator in P3 FLASH Study in CTCL…

    By David Bautz, PhD NASDAQ: SNGX READ THE FULL SNGX RESEARCH REPORT Soligenix, Inc. (NASDAQ: SNGX) is currently conducting a Phase 3 clinical trial of SGX301 in patients with cutaneous T cell lymphoma (CTCL). The FLASH (Fluorescent Light Activated Synthetic Hypericin) trial is a randomized, double blind, placebo controlled study that was originally expected to… Read More..

    Share this:
  • 14 Feb

    SELLAS Life Sciences Provides Regulatory Update for Nelipepimut-S (NPS) for Triple Negative Breast Cancer (TNBC) Following FDA Feedback

    Regulatory clarity on registration-enabling Phase 3 study design of NPS in combination with trastuzumab in TNBC patients in the adjuvant setting enhances business development efforts NEW YORK, Feb. 14, 2020 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused… Read More..

    Share this:
« Previous 1 … 104 105 106 107 108 … 182 Next »
  • PCG Advisory GroupFollow

    PCG Advisory Group
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    10h

    Aemetis “Carbon Zero” Solar Energy and Energy Efficiency Upgrades Supported by $16.8 Million of California CEC and Utility Grants https://t.co/3Cf8EJUTj6 #AMTX $AMTX #cleanenergy #carbonzero #NASDAQ #investors #stockmarket #microcapstocks #smallcapstocks

    Reply on Twitter 1352648521913139202Retweet on Twitter 1352648521913139202Like on Twitter 1352648521913139202Twitter 1352648521913139202
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    21 Jan

    Is it time to disrupt the internet? PCG interviews the latest addition to the @Bubblrhq Advisory Board: Xbox Co- Founder Otto Berkes. https://t.co/kmYycIUKCu

    Reply on Twitter 1352305134286594054Retweet on Twitter 1352305134286594054Like on Twitter 13523051342865940544Twitter 1352305134286594054
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    20 Jan

    Hoth Therapeutics Announces Positive Initial Mechanism of Action Data for HT-003 In Pursuit for Acne Treatment Indication $HOTH #HOTH #acnetreatment #stockmarket #investment #smallcaps #microcaps https://t.co/JO959qrooA

    Reply on Twitter 1351927900233216000Retweet on Twitter 1351927900233216000Like on Twitter 1351927900233216000Twitter 1351927900233216000
    Load More...
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2020 PCG Advisory.

    logo
    • About
    • Services
    • Clients
    • Client Media
      • Client News
      • Client Videos
      • CEO Insights
      • PCG Podcasts
    • PCG Research
    • PCG Digital
    • Contact